Sustaining Sponsors

Donors making a three-year commitment of $25,000-$49,999 per year. Their generous support is crucial to Keystone Symposia's ability to plan future scientific conferences focused on emerging topics and excellence in science.

If your organization is interested in joining these entities in support of Keystone Symposia, please contact:

Amanda Deem, Assistant Director of Development, Email: AmandaD@keystonesymposia.org, Phone:+1 970-262-2668

Click here for more information on Industry Support and Recognition Opportunities.
Abide Therapeutics Inc. Arena Pharmaceuticals, Inc. Astellas Pharma Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Cell Signaling Technology, Inc. Editas Medicine, Inc.
EMD Serono Research and Development Institute, Inc. Genmab A/S Gilead Sciences, Inc.
ImmunoGen, Inc. Intercept Pharmaceuticals, Inc. Juno Therapeutics
MedImmune Mersana Therapeutics Moderna Therapeutics
MorphoSys AG Nestlé Institute of Health Sciences Novartis Institutes for BioMedical Research
OncoMed Pharmaceuticals, Inc. Sangamo Therapeutics, Inc. Sanofi US
Shire Human Genetic Therapies TESARO, Inc. Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals Incorporated    



Sponsors

Donors contributing $25,000-$49,999. These generous gifts allow us to convene meetings in a wide variety of important areas, many of which are in the early stages of research. Special thanks to these organizations for consistent, annual Sponsor-level support.

If your organization is interested in joining these entities in support of Keystone Symposia, please contact:

Amanda Deem, Assistant Director of Development, Email: AmandaD@keystonesymposia.org, Phone:+1 970-262-2668

Click here for more information on Industry Support and Recognition Opportunities.
AbbVie Inc. Akebia Therapeutics Biogen
Bristol-Myers Squibb Company Burroughs Wellcome Fund California Institute for Regenerative Medicine (CIRM)
GlaxoSmithKline Ionis Pharmaceuticals, Inc. Janssen R&D: Pharmaceutical Companies of Johnson & Johnson
Japanese Society of Anti-Aging Medicine Educational grant from Lilly Taylor & Francis
Theravance Biopharma
This activity was supported by an educational grant from Celgene Corporation